StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
086040.KQ$2525.00-3.99%
Fair $2525.00+0.0%

086040.KQ

Biotoxtech Co., Ltd.

Unknown / UnknownKOSDAQ

$2525.00

-105.00 (-3.99%)

Fairly Valued+0.0%Fair Value $2525.00Fund rank 26/100 · Data gapFallback financials|
SA 24/D
F-Score: 8/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $-9.5B · quality 43.7/100

Data gap 26/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 27/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

24/100

D

Piotroski

8/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is 2.9%, below the 5% threshold
Thesis & Journal · 086040.KQLocal privado en este navegador · Biotoxtech Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$38.9B

P/E

34.1x

↑

EV/EBITDA

8.9x

↓

ROE

2.9%

↓

Gross Margin

12.5%

↓

Debt/Equity

1.56

↑
52-Week Range$2525
$2470$4115

TradingView lightweight chart

086040.KQ price, volumen y niveles de valoración

Último $2,525Periodo -64.7%
Fair value: $2,525

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+8.0%

FCF CAGR

—

FCF margin

9.4%

FCF / Net income

3.79x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $47.02B · net income $1.16B · FCF $4.40B

2022-FY → 2025-FY

Gross margin

12.5%-21.0% pts

Operating margin

-10.2%-12.4% pts

Net margin

2.5%-4.8% pts

FCF margin

9.4%+95.4% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$47.02B$47.02B$41.34B$32.63B$37.29B
Net Income$1.16B$1.16B$-6.43B$-4.88B$2.73B
EBITDA$9.41B$9.41B$362.9M$-4.39B$3.32B
EPS74.0074.00-417.00-316.00186.00
Gross Margin12.5%12.5%6.2%5.8%33.5%
Operating Margin-10.2%-10.2%-20.8%-25.1%2.1%
Net Margin2.5%2.5%-15.5%-14.9%7.3%
Balance Sheet
Debt/Equity1.561.561.571.191.11
Cash Flow
Free Cash Flow$4.40B$4.40B$-9.50B$-21.12B$-32.09B
Returns
ROE2.9%2.9%-16.0%-9.4%6.2%
Valuation
P/E34.1234.12——43.66
EV/EBITDA8.888.88282.78—46.87
P/B0.990.991.271.992.69
Growth & Yield
Revenue Growth13.7%13.7%26.7%-12.5%—
EPS Growth117.7%117.7%-32.0%-269.9%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

44.7%

muy exigente

EPS terminal req.

$224.05

Spread vs growth

73.1%

5Y implied EPS CAGR

29.7%

muy exigente

EPS terminal req.

$271.10

Spread vs growth

88.1%

10Y implied EPS CAGR

19.4%

exigente

EPS terminal req.

$436.61

Spread vs growth

98.3%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -12.8%

Total return

-12.8%

Start / end P/E

n/dx → n/dx

EPS bridge

-417.00 → 74.00

Residual

-12.8%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-12.8%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.